Letter: effectiveness of golimumab to induce remission in outpatient ulcerative colitis in Italy

Aliment Pharmacol Ther. 2016 Mar;43(5):657-8. doi: 10.1111/apt.13509.

Authors

A Tursi¹, N Della Valle², A Penna³, G Pranzo⁴, C Ricciardelli⁵, M Picchio⁶

Affiliations

¹ Gastroenterology Service, ASL BAT, Andria, Italy. antotursi@tiscali.it.
² Division of Gastroenterology, A.O. "Ospedali Riuniti", Foggia, Italy.
³ Division of Gastroenterology, "S. Paolo" Hospital", Bari, Italy.
⁴ Ambulatory of IBD, "Valle D'Itria" Hospital, Martina Franca, Italy.
⁵ Division of Gastroenterology, "Veris Delli Ponti" Hospital, Scorrano, Italy.
⁶ Division of Surgery, "P. Colombo" Hospital, Velletri, Italy.

PMID: 26843348
DOI: 10.1111/apt.13509

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Colitis, Ulcerative / drug therapy*
Female
Humans
Male
Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

Antibodies, Monoclonal
Tumor Necrosis Factor-alpha